干细胞银行市场规模、份额、成长分析、按来源、按服务类型、按应用、按地区 - 产业预测，2024-2031 年

2022年全球干细胞库市场规模为91亿美元，从2023年的98.5亿美元成长到2031年的186.5亿美元，复合年增长率预计将成长18.30%。

由于冷冻保存和细胞库製备过程的进步，全球干细胞库市场正在经历快速成长。在单株抗体和高效能生物製药的普及推动下，干细胞疗法的日益普及，大大推动了市场需求。基于干细胞的疗法，特别是造血移植的持续研究和开发，为神经退化性疾病疾病和心血管疾病的治疗提供了有希望的机会。组织库和生物库在保存各种临床应用的成体组织和干细胞方面发挥着至关重要的作用，低温冷冻可确保其长期生存能力。针对以前无法治疗的疾病的 IPS 细胞等再生医学的开拓将进一步提振市场。此外，晚婚的趋势增加了人们对脐带血库作为生物保险形式的兴趣，从而显着推动了市场成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 监管环境
• 案例研究分析
• 技术分析
• 供应链分析
• 价值链分析
• PESTEL分析

干细胞银行市场：依来源分类

• 市场概况
• 胎盘干细胞（PSCS）
• 脂肪组织源性干细胞（ADSCS）
• 骨髓来源干细胞（BMSCS）
• 人类胚胎干细胞（HESCS）
• 牙髓干细胞（DPSCS）
• 其他来源

干细胞银行市场：依服务类型

• 市场概况
• 样品保存及保存
• 样品分析
• 样品加工
• 样本采集和运输

干细胞银行市场：依应用分类

• 市场概况
• 个性化银行应用程式
• 研究用途
  • 疾病治疗研究
  • 生命科学研究
  • 药物发现
• 临床应用
  • 造血系统疾病
  • 自体免疫疾病
  • 其他疾病

干细胞银行市场：依地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Cordlife（Singapore）
• Cryo-Cell International（US）
• LifeCell International（India）
• StemCyte（US）
• Global Cord Blood（Hong Kong）
• Smart Cells International（UK）
• Vita34（Germany）
• CryoHoldco（US）
• Cellerant Therapeutics, Inc.（US）
• StemCell Technologies Inc.（Canada）
• Regenexx（US）
• Athersys, Inc.（US）
• Mesoblast Limited（Australia）
• Cytori Therapeutics, Inc.（US）
• OrthoGenics（US）
• Panthera Biopartners（UK）
• Stemson Therapeutics（US）
• Lonza Group AG（Switzerland）
• Macopharma（France）
• Cure Cell（Turkey）
• LifeBankUSA（US）
• Biolife Plasma Services, LLC（US）
• NexImmune, Inc.（US）

Global Stem Cell Banking Market size was valued at USD 9.1 billion in 2022 and is poised to grow from USD 9.85 billion in 2023 to USD 18.65 billion by 2031, growing at a CAGR of 18.30% during the forecast period (2024-2031).

The global stem cell banking market is witnessing rapid growth driven by advancements in cryopreservation and cell bank preparation processes. The rising adoption of stem cell therapy, fueled by the popularity of monoclonal antibodies and efficient biopharmaceuticals, is significantly enhancing market demand. Continuous R&D in stem cell-based therapies, particularly for hematopoietic transplantation, offers promising opportunities for treating neurodegenerative and cardiovascular diseases. Tissue banks and biobanks play a pivotal role in storing adult tissues and stem cells for diverse clinical applications, while cryogenic freezing ensures their long-term viability. The development of regenerative medicine, such as IPS cells for previously untreatable conditions, further boosts the market. Additionally, the trend of late parenthood has heightened interest in umbilical cord blood banking as a form of biological insurance, significantly driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Banking Market Segmental Analysis

Global Stem Cell Banking Market is segmented by Source, Service Type, Application, and region. Based on Source, the market is segmented into Placental Stem Cells (PSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem Cells (DPSCS), and Other Stem Cell Sources. Based on Service Type, the market is segmented into Sample Preservation and Storage, Sample Analysis, Sample Processing, and Sample Collection and Transportation. Based on Application, the market is segmented into Personalized Banking Applications, Research Applications, and Clinical Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Stem Cell Banking Market

Our analysis reveals that the global stem cell banking market is experiencing a significant shift toward the use of adult stem cells, particularly those derived from bone marrow or adipose tissue. These stem cells are gaining traction due to their ethical acceptability and ease of accessibility compared to embryonic stem cells. Additionally, advancements in minimally invasive collection techniques, such as needle-based bone marrow extraction, are enhancing patient convenience and reducing discomfort. This progress is driving increased adoption and awareness of stem cell banking, as it provides a reliable and patient-friendly option for preserving valuable biological resources. Consequently, these developments are propelling the growth and popularity of the stem cell banking market worldwide.

Restraints in the Global Stem Cell Banking Market

The global stem cell banking market faces a significant restraint in the form of ever-evolving regulatory frameworks. Governments worldwide are enforcing stringent guidelines to ensure safety and uphold ethical standards in stem cell research and banking. However, navigating these intricate and frequently changing regulatory landscapes presents a considerable challenge for market players. The continuous evolution or unpredictability of regulations often disrupts operations and hinders market growth. Companies must invest substantial resources to stay compliant, adapting their practices to align with new requirements, which can strain financial and operational capacities. This regulatory uncertainty not only adds complexity but also discourages potential investments and innovation in the sector, thereby acting as a barrier to the market's overall expansion.

Market Trends of the Global Stem Cell Banking Market

The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is driving the demand for innovative treatment solutions globally. Stem cell therapies are emerging as a promising approach to treat and potentially cure these chronic illnesses, showcasing transformative potential in healthcare. As a result, there is a rising need for readily available stem cell sources, which is fueling the growth of stem cell banking services. By providing a reliable repository for stem cells, these banks are positioned to support advancements in regenerative medicine and personalized treatments, catering to the evolving needs of the healthcare industry. This trend underscores the critical role of stem cell banking in shaping the future of disease management and therapeutic innovation.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Case Study Analysis
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis
• PESTEL Analysis

Stem Cell Banking Market by Source

• Market Overview
• Placental Stem Cells (PSCS)
• Adipose Tissue-Derived Stem Cells (ADSCS)
• Bone Marrow-Derived Stem Cells (BMSCS)
• Human Embryo-Derived Stem Cells (HESCS)
• Dental Pulp-Derived Stem Cells (DPSCS)
• Other Stem Cell Sources

Stem Cell Banking Market by Service Type

• Market Overview
• Sample Preservation and Storage
• Sample Analysis
• Sample Processing
• Sample Collection and Transportation

Stem Cell Banking Market by Application

• Market Overview
• Personalized Banking Applications
• Research Applications
  • Disease Treatment Studies
  • Life Science Research
  • Drug Discovery
• Clinical Applications
  • Hematopoietic Disorders
  • Autoimmune Disorders
  • Other Diseases

Stem Cell Banking Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Cordlife (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell International (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Cord Blood (Hong Kong)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Cells International (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vita34 (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoHoldco (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellerant Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regenexx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athersys, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoGenics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panthera Biopartners (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemson Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cure Cell (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeBankUSA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolife Plasma Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexImmune, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments